Skip to content

Research on FibroTouch noninvasive evaluation of liver fibrosis and cirrhosis

Research on FibroTouch noninvasive evaluation of liver fibrosis and cirrhosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-14004429
Enrollment
Unknown
Registered
2014-03-10
Start date
2014-03-03
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic hepatitis B

Interventions

Gold Standard:
Index test:

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years, non-limited gender; 2. History of HBV or HBsAg positive>6 months up to now; 3. Three months around Fibrotouch, with qualified liver biopsy for pathological diagnosis is accepted; 4. without chemical therapy history of powerful medicine to lower enzyme in the two weeks before blood biochemical detection.(dimethyl diphenyl bicarboxylate and bicyclol); 5. Participant agreed and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. The people who are unable or unwilling to sign informed consent form; 2. The people who have merger of hepatitis c, alcohol and non-alcoholic fatty liver disease, autoimmune liver disease, inherited metabolic liver disease, biliary systemic disease or liver and gall parasitic diseases; 3. The people who have other serious chronic disorders or history of malignancy; 4. The people with ALT =5 ULN in the past 1 month; 5. The people with WBC<3.5×10^9/L, PLT<60×10^9/L, PTA<60%; 6. The people with DBIL=1.5 ULN; 7. The people with decompensated cirrhosis (especially the people with ascites); 8. Pregnant or lactating women, or women who have a pregnant plan and don't want to birth control in the study period; 9. The people who have wound on the right upper abdomen recently; 10. The people who have various space-occupying tumor or cyst in right liver; 11. The people who have none or limited legal capacity.

Design outcomes

Primary

MeasureTime frame
Liver stiffness value;

Countries

China

Contacts

Public ContactJidong Jia

Beijing Friendship Hospital

jiamd@263.net+86 010 63139816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026